SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-176473
Filing Date
2022-06-17
Accepted
2022-06-17 16:01:09
Documents
12
Period of Report
2022-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d370205d8k.htm   iXBRL 8-K 32816
  Complete submission text file 0001193125-22-176473.txt   151104

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA plrx-20220616.xsd EX-101.SCH 2860
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE plrx-20220616_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plrx-20220616_pre.xml EX-101.PRE 10815
6 EXTRACTED XBRL INSTANCE DOCUMENT d370205d8k_htm.xml XML 3245
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 221023655
SIC: 2834 Pharmaceutical Preparations